🔗 Permalink

Inventor profile of:

Nathaniel Silver

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2026-03-12

Top Assignees for applications by Nathaniel Silver

The entities that hold a legal rights for patent applications filed by inventor Silver Nathaniel:

AXCELLA HEALTH INC. 2 Cambridge, MA United States
Generation Bio Co. 2 Cambridge, MA United States

Recent patent applications by Silver Nathaniel

Nathaniel Silver from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-12

US20260069656A1

Human necessities

Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof

#2 | 2026-02-12

US20260041643A1

Human necessities

STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING

#3 | 2025-11-20

US20250352666A1

Human necessities

LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF

#4 | 2025-09-11

US20250282848A1

Chemistry; metallurgy

NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FVIII THERAPEUTICS

#5 | 2025-09-11

US20250281647A1

Human necessities

STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING

#6 | 2024-11-21

US20240382432A1

Human necessities

SINGLE CHAIN VARIABLE FRAGMENT (SCFV) MODIFIED LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF

#7 | 2024-09-12

US20240299580A1

Human necessities

APOE AND APOB MODIFIED LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF

#8 | 2024-08-22

US20240277833A1

Human necessities

NON-VIRAL DNA VECTORS FOR VACCINE DELIVERY

#9 | 2024-07-11

US20240226324A1

Human necessities

NON-VIRAL DNA VECTORS EXPRESSING THERAPEUTIC ANTIBODIES AND USES THEREOF

#10 | 2024-07-04

US20240216535A1

Human necessities

NON-VIRAL DNA VECTORS EXPRESSING ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF

#11 | 2024-06-06

US20240181085A1

Human necessities

NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING PFIC THERAPEUTICS

#12 | 2024-01-25

US20240026374A1

Chemistry; metallurgy

CLOSED-ENDED DNA VECTORS AND USES THEREOF FOR EXPRESSING PHENYLALANINE HYDROXYLASE (PAH)

#13 | 2023-11-30

US20230383311A1

Chemistry; metallurgy

NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FVIII THERAPEUTICS

#14 | 2023-05-04

US20230138409A1

Human necessities

NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FACTOR IX THERAPEUTICS

#15 | 2023-05-04

US20230134550A1

Human necessities

NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING GAUCHER THERAPEUTICS

#16 | 2023-01-26

US20230024354A1

Human necessities

NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING PHENYLALANINE HYDROXYLASE (PAH) THERAPEUTICS

#17 | 2022-06-09

US20220177545A1

Chemistry; metallurgy

NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FVIII THERAPEUTICS

#18 | 2022-02-10

US20220042035A1

Chemistry; metallurgy

NON-VIRAL DNA VECTORS AND USES THEREOF FOR ANTIBODY AND FUSION PROTEIN PRODUCTION

#19 | 2020-10-01

US20200306342A1

Human necessities

Nutritive polypeptides and formulations thereof, and methods of production and use thereof

#20 | 2020-06-18

US20200188481A1

Human necessities

Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof

#21 | 2016-11-24

US20160339078A1

Human necessities

Nutritive polypeptides and formulations thereof, and methods of production and use thereof

InventorID:

1715997 ⎘